Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT06407934

Public ClinicalTrials.gov record NCT06407934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group 52-week Extension Study to Evaluate the Treatment Response and Safety of Two Amlitelimab Dose Regimens Administered by Subcutaneous Injection in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 years and older diagnosed with moderate-to-severe atopic dermatitis (AD). The primary objective of ESTUARY is to assess the maintenance of treatment response on continued Q12W dosing compared to treatment withdrawal. Study details include: The study duration will be up to 68 weeks including a 52-week randomized double-blind period, and a 16-week safety follow-up for participants not entering the LTS17367 (RIVER-AD). The study duration will be up to 52 weeks for participants entering the LTS17367 \[RIVER-AD\] study at the Week 52 visit of EFC17600 (ESTUARY).

Study identification

NCT ID
NCT06407934
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,541 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2024 (Actual)
Primary completion
Jun 10, 2026 (Actual)
Completion
Mar 17, 2027 (Estimated)
Last update posted
Jul 10, 2026

2024 – 2027

United States locations

U.S. sites
82
U.S. states
28
U.S. cities
70
Facility City State ZIP Site status
Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham Alabama 35244 —
Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale Arizona 85260 —
Scottsdale Clinical Trials- Site Number : 8401149 Scottsdale Arizona 85260 —
Eclipse Clinical Research- Site Number : 8401158 Tucson Arizona 85745 —
Johnson Dermatology- Site Number : 8401076 Fort Smith Arkansas 72916 —
Encino Research Center- Site Number : 8401042 Encino California 91436 —
First OC Dermatology- Site Number : 8401025 Fountain Valley California 92708 —
Center for Dermatology Clinical Research- Site Number : 8401018 Fremont California 94538 —
Marvel Clinical Research- Site Number : 8401102 Huntington Beach California 92647 —
Sunwise Clinical Research- Site Number : 8401022 Lafayette California 94549 —
Torrance Clinical Research - Narbonne Avenue- Site Number : 8401027 Lomita California 90717 —
Dermatology Research Associates - Los Angeles- Site Number : 8401092 Los Angeles California 90045 —
LA Universal Research Center- Site Number : 8401064 Los Angeles California 90057 —
Northridge Clinical Trials - Northridge- Site Number : 8401080 Northridge California 91325 —
Cura Clinical Research - Oxnard- Site Number : 8401142 Oxnard California 93030 —
Southern California Dermatology- Site Number : 8401043 Santa Ana California 92701 —
Clinical Science Institute- Site Number : 8401028 Santa Monica California 90404 —
UConn Health - Farmington- Site Number : 8401115 Farmington Connecticut 06030 —
Pediatric Skin Research- Site Number : 8401198 Coral Gables Florida 33146 —
St. Jude Clinical Research- Site Number : 8401287 Doral Florida 33172 —
Beth Israel Deaconess Medical Center - Fort Myers- Site Number : 8401286 Fort Myers Florida 33919 —
Direct Helpers Research Center- Site Number : 8401056 Hialeah Florida 33012 —
Encore Medical Research - Hollywood- Site Number : 8401030 Hollywood Florida 33024 —
Clever Medical Research- Site Number : 8401160 Miami Florida 33126 —
Acevedo Clinical Research Associates- Site Number : 8401088 Miami Florida 33142 —
Florida International Research Center- Site Number : 8401091 Miami Florida 33173 —
Miami Dermatology and Laser Research - Miami - Southwest 87th Avenue- Site Number : 8401086 Miami Florida 33173 —
Anchor Medical Research- Site Number : 8401300 Miami Florida 33176 —
Savin Medical Group - Miami Lakes- Site Number : 8401085 Miami Lakes Florida 33014 —
Nuline Clinical Trial Center- Site Number : 8401161 Pompano Beach Florida 33060 —
Global Clinical Professionals (GCP)- Site Number : 8401045 St. Petersburg Florida 33705 —
Clinical Research Trials of Florida- Site Number : 8401023 Tampa Florida 33607 —
AllerVie Clinical Research - Columbus- Site Number : 8401104 Columbus Georgia 31904 —
Cleaver Medical Group- Site Number : 8401138 Dawsonville Georgia 30534 —
First Georgia Physician Group- Site Number : 8401190 Fayetteville Georgia 30214 —
Skin Care Physicians of Georgia - Macon- Site Number : 8401034 Macon Georgia 31217 —
Javara Research - Thomasville- Site Number : 8401189 Thomasville Georgia 31792 —
Rophe Adult & Pediatric Medicine- Site Number : 8401289 Union City Georgia 30291 —
NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8401038 Skokie Illinois 60077 —
Dawes Fretzin Clinical Research- Site Number : 8401015 Indianapolis Indiana 46256 —
Equity Medical - Bowling Green- Site Number : 8401296 Bowling Green Kentucky 42104 —
Skin Sciences- Site Number : 8401039 Louisville Kentucky 40217 —
MedPharmics - Covington- Site Number : 8401137 Covington Louisiana 70433 —
BRCR Global Gretna- Site Number : 8401243 Gretna Louisiana 70053 —
Velocity Clinical Research - Lafayette- Site Number : 8401152 Lafayette Louisiana 70508 —
MetroBoston Clinical Partners - Brighton- Site Number : 8401128 Brighton Massachusetts 02135 —
Henry Ford Hospital- Site Number : 8401044 Detroit Michigan 48202 —
Revival Research Institute - Troy- Site Number : 8401012 Troy Michigan 48084 —
Oakland Medical Center- Site Number : 8401116 Troy Michigan 48085 —
Allergy & Immunology Associates of Ann Arbor- Site Number : 8401078 Ypsilanti Michigan 48197 —
SKY Integrative Medical Center/SKYCRNG - Ridgeland- Site Number : 8401058 Ridgeland Mississippi 39157 —
Skin Specialists- Site Number : 8401068 Omaha Nebraska 68144 —
Jubilee Clinical Research- Site Number : 8401054 Las Vegas Nevada 89106 —
Care Access - Hoboken- Site Number : 8401132 Hoboken New Jersey 07030 —
The University of New Mexico- Site Number : 8401263 Albuquerque New Mexico 87106 —
Equity Medical- Site Number : 8401239 New York New York 10023 —
Icahn School of Medicine at Mount Sinai- Site Number : 8401129 New York New York 10029 —
Sadick Research Group - New York - Park Avenue- Site Number : 8401050 New York New York 10075 —
OptiSkin- Site Number : 8401163 New York New York 10128 —
AXIS Clinicals - Fargo- Site Number : 8401196 Fargo North Dakota 58103 —
Bexley Dermatology Research- Site Number : 8401051 Bexley Ohio 43209 —
Apex Clinical Research Center- Site Number : 8401237 Mayfield Heights Ohio 44124 —
Oregon Medical Research Center- Site Number : 8401017 Portland Oregon 97201 —
Best Skin Research - Camp Hill- Site Number : 8401031 Camp Hill Pennsylvania 17011 —
Paddington Testing Company- Site Number : 8401041 Philadelphia Pennsylvania 19103 —
Clinical Research of Philadelphia- Site Number : 8401193 Philadelphia Pennsylvania 19114 —
Dermatology Associates of Plymouth Meeting- Site Number : 8401147 Plymouth Meeting Pennsylvania 19462 —
Columbia Dermatology & Aesthetics- Site Number : 8401166 Columbia South Carolina 29212 —
Tribe Clinical Research - Greenville - Verdae Boulevard- Site Number : 8401225 Greenville South Carolina 29607 —
Health Concepts- Site Number : 8401059 Rapid City South Dakota 57702 —
Arlington Research Center- Site Number : 8401248 Arlington Texas 76011 —
Dermatology Treatment and Research Center- Site Number : 8401164 Dallas Texas 75230 —
Derm Texas- Site Number : 8401217 Dallas Texas 75235 —
Prolato Clinical Research Center- Site Number : 8401209 Houston Texas 77054 —
SMS Clinical Research- Site Number : 8401182 Mesquite Texas 75149 —
Synapse Clinical Research - Missouri City- Site Number : 8401148 Missouri City Texas 77459 —
Texas Dermatology and Laser Specialists - San Antonio - Oakwell Court- Site Number : 8401131 San Antonio Texas 78218 —
Stryde Research - Epiphany Dermatology- Site Number : 8401185 Southlake Texas 76092 —
Complete Dermatology - Sugar Land- Site Number : 8401061 Sugar Land Texas 77479 —
Tanner Clinic - Layton Antelope A- Site Number : 8401151 Layton Utah 84041 —
Care Access - Arlington- Site Number : 8401134 Arlington Virginia 22206 —
Virginia Dermatology & Skin Cancer Center- Site Number : 8401047 Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 242 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06407934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06407934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →